Related Experiment Video
Updated: Jun 3, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
The transcriptome that mediates increased cyclic adenosine monophosphate signaling in PRKAR1A defects and other
Monalisa F Azevedo1, Constantine A Stratakis
1Section on Endocrinology and Genetics, Program on Developmental Endocrinology & Genetics, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.
Objective:
To review current knowledge on the involvement of cyclic adenosine monophosphate (cAMP) and interacting signaling pathways in predisposition to tumor formation in primary pigmented nodular adrenocortical disease (PPNAD), a type of bilateral adrenal hyperplasia (BAH) related to the multiple endocrine neoplasia Carney complex, and also in isolated PPNAD and other BAHs.
Methods:
We review the pertinent literature and discuss genetic defects associated with various endocrine and nonendocrine tumors.
Results:
A decade ago, we discovered that PPNAD and the Carney complex are caused by PRKAR1A mutations. PRKAR1A encodes the protein kinase A (PKA) regulatory subunit type IA, an important regulator of cAMP signaling in most cells. Recently, we described PKA or PRKAR1A abnormalities in a variety of other BAHs; in some of these cases, mutations in additional genes of the cAMP signaling pathway, the phosphodiesterases, were identified. Transcriptomic analyses of human lesions or animal models showed that abnormal cAMP/PKA signaling in the adrenal glands, and also in other tissues such as bone, leads to proliferation of tissue-specific pluripotential cells through activation of Wnt signaling.
Conclusion:
Recent findings indicate the relevance of cAMP signaling in the pathogenesis of adrenocortical disease and point to the Wnt signaling pathway as a potential important mediator of tumorigenesis related to increased cAMP or PKA signaling (or both).
Insights
Cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) signaling are key in developing adrenal hyperplasia and tumors. Abnormalities in cAMP/PKA and Wnt signaling pathways contribute to tumor formation in conditions like PPNAD.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Primary pigmented nodular adrenocortical disease (PPNAD) and Carney complex are linked to bilateral adrenal hyperplasia (BAH).
- Understanding the molecular mechanisms driving these conditions is crucial for effective treatment and prevention.
Purpose of the Study:
- To review the role of cyclic adenosine monophosphate (cAMP) and associated signaling pathways in tumor formation.
- To explore the involvement of these pathways in PPNAD, Carney complex, and other forms of BAH.
Main Methods:
- Literature review of current knowledge on cAMP signaling and related pathways.
- Discussion of genetic defects identified in endocrine and nonendocrine tumors.
Main Results:
- PRKAR1A mutations, affecting cAMP/protein kinase A (PKA) signaling, are implicated in PPNAD and Carney complex.
- Abnormalities in cAMP/PKA signaling and phosphodiesterase genes are found in various BAHs.
- Aberrant cAMP/PKA signaling activates Wnt signaling, promoting tissue-specific cell proliferation and tumorigenesis.
Conclusions:
- cAMP signaling plays a significant role in the pathogenesis of adrenocortical diseases.
- The Wnt signaling pathway is a potential mediator of tumorigenesis driven by aberrant cAMP or PKA signaling.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Global Regulatory Systems
Intracellular Signaling Cascades
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...